Cargando…

TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2

Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited neurodegenerative disease, which belongs to the trinucleotide repeat disease group with a CAG repeat expansion in exon 1 of the ATXN2 gene resulting in an ataxin-2 protein with an expanded polyglutamine (polyQ)-stretch. The di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bux, Jessica, Sen, Nesli Ece, Klink, Isa-Maria, Hauser, Stefan, Synofzik, Matthis, Schöls, Ludger, Auburger, Georg, Riess, Olaf, Hübener-Schmid, Jeannette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122633/ https://www.ncbi.nlm.nih.gov/pubmed/36894829 http://dx.doi.org/10.1007/s12035-023-03294-y

Ejemplares similares

Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice
por: Nguyen, Huu Phuc, et al.
Publicado: (2013)

Ataxin-3, The Spinocerebellar Ataxia Type 3 Neurodegenerative Disorder Protein, Affects Mast Cell Functions
por: Sowa, Anna S., et al.
Publicado: (2022)

Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 Deubiquitination
por: Harmuth, Tina, et al.
Publicado: (2022)

Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3
por: Menzies, Fiona M., et al.
Publicado: (2010)

PINK1 and Ataxin-2 as modifiers of growth
por: Sen, Nesli E., et al.
Publicado: (2017)

PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study
por: Gonsior, Kathrin, et al.
Publicado: (2020)

Motor Training in Degenerative Spinocerebellar Disease: Ataxia-Specific Improvements by Intensive Physiotherapy and Exergames
por: Synofzik, Matthis, et al.
Publicado: (2014)

Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3
por: Garcia‐Moreno, Hector, et al.
Publicado: (2022)

Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons
por: Hauser, Stefan, et al.
Publicado: (2021)

Stage-dependent biomarker changes in spinocerebellar ataxia type 3
por: Faber, Jennifer, et al.
Publicado: (2023)

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
por: Wilke, Carlo, et al.
Publicado: (2020)

Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models
por: Matos, Carlos A., et al.
Publicado: (2016)

Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1
por: Chen, Jiu-Ming, et al.
Publicado: (2022)

Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3
por: Koike, Yuka, et al.
Publicado: (2021)

Partial Loss of Ataxin-1 Function Contributes to Transcriptional Dysregulation in Spinocerebellar Ataxia Type 1 Pathogenesis
por: Crespo-Barreto, Juan, et al.
Publicado: (2010)

Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3
por: Harmuth, Tina, et al.
Publicado: (2018)

Case Report: Deep brain stimulation improves tremor in FGF-14 associated spinocerebellar ataxia
por: Loeffler, Moritz A., et al.
Publicado: (2022)

In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism
por: Sen, Nesli-Ece, et al.
Publicado: (2019)

Correspondence on “Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment” by Roux et al.
por: Park, Joohyun, et al.
Publicado: (2021)

Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies
por: Evers, Melvin M., et al.
Publicado: (2013)

Histone deacetylase-3 interacts with ataxin-7 and is altered in a spinocerebellar ataxia type 7 mouse model
por: Duncan, Carlotta E, et al.
Publicado: (2013)

Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3
por: Johnson, Sean L., et al.
Publicado: (2021)

Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2
por: Afonso, Inês T., et al.
Publicado: (2022)

Short-read genome sequencing allows ‘en route’ diagnosis of patients with atypical Friedreich ataxia
por: Fleszar, Zofia, et al.
Publicado: (2023)

Real‐time use of audio‐biofeedback can improve postural sway in patients with degenerative ataxia
por: Fleszar, Zofia, et al.
Publicado: (2018)

Identifying Niemann–Pick type C in early-onset ataxia: two quick clinical screening tools
por: Synofzik, Matthis, et al.
Publicado: (2016)

Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients
por: Ashton, Catherine, et al.
Publicado: (2023)

Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult‐onset disorder
por: Schmitz‐Hübsch, Tanja, et al.
Publicado: (2021)

Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in Drosophila models of Spinocerebellar Ataxia Type 3
por: Prifti, Matthew V., et al.
Publicado: (2023)

Ataxin-1 oligomers induce local spread of pathology and decreasing them by passive immunization slows Spinocerebellar ataxia type 1 phenotypes
por: Lasagna-Reeves, Cristian A, et al.
Publicado: (2015)

Indirect Negative Effect of Mutant Ataxin-1 on Short- and Long-Term Synaptic Plasticity in Mouse Models of Spinocerebellar Ataxia Type 1
por: Shuvaev, Anton N., et al.
Publicado: (2022)

Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27B
por: Bonnet, Céline, et al.
Publicado: (2023)

An understanding of spinocerebellar ataxia
por: Ramachandra, N.B., et al.
Publicado: (2015)

Parkinsonism in Spinocerebellar Ataxia
por: Park, Hyeyoung, et al.
Publicado: (2015)

Spinocerebellar ataxia: an update
por: Sullivan, Roisin, et al.
Publicado: (2018)

Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3
por: Mengel, David, et al.
Publicado: (2023)

Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3
por: Faber, Jennifer, et al.
Publicado: (2021)

Uniparental disomy determined by whole‐exome sequencing in a spectrum of rare motoneuron diseases and ataxias
por: Bis, Dana M., et al.
Publicado: (2017)

Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
por: Toonen, Lodewijk J. A., et al.
Publicado: (2018)

Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias
por: Gan, Shi-Rui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hqju59o7j476esbmo9j85dg2ah